BC
PETX
Broadfin Capital’s Aratana Therapeutics, Inc. PETX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-7,258,135
| Closed | -$37.5M | – | 49 |
|
|
2019
Q2 | $37.5M | Hold |
7,258,135
| – | – | 8.15% | 2 |
|
|
2019
Q1 | $26.1M | Buy |
7,258,135
+3,175,000
| +78% | +$11.4M | 5.4% | 4 |
|
|
2018
Q4 | $25M | Hold |
4,083,135
| – | – | 3.29% | 4 |
|
|
2018
Q3 | $23.8M | Sell |
4,083,135
-211,291
| -5% | -$1.23M | 3.51% | 8 |
|
|
2018
Q2 | $18.3M | Hold |
4,294,426
| – | – | 2.87% | 12 |
|
|
2018
Q1 | $18.9M | Hold |
4,294,426
| – | – | 2.95% | 13 |
|
|
2017
Q4 | $22.6M | Sell |
4,294,426
-890,516
| -17% | -$4.68M | 3.69% | 11 |
|
|
2017
Q3 | $31.8M | Hold |
5,184,942
| – | – | 4.7% | 7 |
|
|
2017
Q2 | $37.5M | Buy |
5,184,942
+1,489,500
| +40% | +$10.8M | 4.55% | 5 |
|
|
2017
Q1 | $19.6M | Hold |
3,695,442
| – | – | 2.37% | 12 |
|
|
2016
Q4 | $26.5M | Buy |
3,695,442
+609,463
| +20% | +$4.38M | 2.95% | 7 |
|
|
2016
Q3 | $28.9M | Sell |
3,085,979
-342,886
| -10% | -$3.21M | 2.59% | 10 |
|
|
2016
Q2 | $21.7M | Hold |
3,428,865
| – | – | 2.11% | 12 |
|
|
2016
Q1 | $18.9M | Hold |
3,428,865
| – | – | 1.83% | 11 |
|
|
2015
Q4 | $19.1M | Buy |
3,428,865
+2,119,000
| +162% | +$11.8M | 1.18% | 16 |
|
|
2015
Q3 | $11.1M | Buy |
1,309,865
+178,000
| +16% | +$1.51M | 0.62% | 38 |
|
|
2015
Q2 | $17.1M | Hold |
1,131,865
| – | – | 0.92% | 28 |
|
|
2015
Q1 | $18.1M | Sell |
1,131,865
-127,606
| -10% | -$2.04M | 1.41% | 15 |
|
|
2014
Q4 | $22.4M | Sell |
1,259,471
-182,964
| -13% | -$3.26M | 1.95% | 15 |
|
|
2014
Q3 | $14.5M | Buy |
1,442,435
+625,000
| +76% | +$6.27M | 1.52% | 20 |
|
|
2014
Q2 | $12.8M | Buy |
817,435
+150,000
| +22% | +$2.34M | 1.24% | 24 |
|
|
2014
Q1 | $12.4M | Buy |
+667,435
| New | +$12.4M | 1.2% | 31 |
|